We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $1.12B
1-Year Est. Return 390.6%
This Fund
S&P 500
This Quarter Est. Return
+31.48%
1 Year Est. Return
+390.6%
3 Year Est. Return
+6,011.55%
5 Year Est. Return
+59,317.78%
10 Year Est. Return
+26,738,243.47%
AUM
$717M
AUM Growth
+$224M
Cap. Flow
+$115M
Cap. Flow %
16.05%
Top 10 Hldgs %
8.55%
Holding
426
New
116
Increased
108
Reduced
81
Closed
120

Top Buys

Rank Stock Value
1
CALD
Callidus Software, Inc.
CALD
+$3.63M
2
ESPR
Esperion Therapeutics
ESPR
+$3.52M
3
CEMP
Cempra, Inc.
CEMP
+$3.46M
4
IRDM icon
Iridium Communications
IRDM
+$3.4M
5
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$3.31M

Top Sells

Rank Stock Value
1
PXLW icon
Pixelworks
PXLW
+$3.85M
2
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$3.82M
3
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$3.65M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$3.53M
5
APPS icon
Digital Turbine
APPS
+$3.47M

Sector Composition

Rank Sector Weight
1 Healthcare 30.43%
2 Technology 19.82%
3 Consumer Discretionary 13.82%
4 Industrials 11.33%
5 Miscellaneous 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
1
DELISTED
Esperion Therapeutics
ESPR
$7.44M 1.04%
184,020
+115,099
+167% +$3.52M
TGTX icon
2
TG Therapeutics
TGTX
$8.57B
$6.82M 0.95%
430,627
+176,734
+70% +$2.3M
RCPT
3
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$6.78M 0.95%
55,327
-344
-0.6% -$34.8K
TTPH
4
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$6.76M 0.94%
8,512
+882
+12% +$475K
FOLD
5
DELISTED
Amicus Therapeutics
FOLD
$6.57M 0.92%
789,840
+177,641
+29% +$1.22M
BLUE
6
DELISTED
bluebird bio
BLUE
$5.65M 0.79%
4,754
+2,485
+110% +$1.66M
IMPV
7
DELISTED
Imperva, Inc.
IMPV
$5.46M 0.76%
110,434
+23,787
+27% +$952K
CEMP
8
DELISTED
Cempra, Inc.
CEMP
$5.44M 0.76%
+231,286
New +$3.46M
RDNT icon
9
RadNet
RDNT
$5.8B
$5.41M 0.76%
633,581
+214,645
+51% +$1.81M
PLNR
10
DELISTED
PLANAR SYSTEMS INC
PLNR
$4.97M 0.69%
593,645
+180,900
+44% +$1.04M
MPAA icon
11
Motorcar Parts of America
MPAA
$229M
$4.78M 0.67%
153,869
+27,493
+22% +$829K
GLIN icon
12
VanEck India Growth Leaders ETF
GLIN
$93.2M
$4.71M 0.66%
105,407
+17,076
+19% +$777K
PTX
13
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$4.71M 0.66%
50,160
+18,161
+57% +$1.73M
MACK
14
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.66M 0.65%
52,395
+17,709
+51% +$1.29M
TDAY
15
USA Today Co
TDAY
$929M
$4.59M 0.64%
194,349
+121,338
+166% +$2.39M
BFX
16
DELISTED
BowFlex Inc.
BFX
$4.59M 0.64%
302,297
+85,357
+39% +$1.14M
SMCI icon
17
Super Micro Computer
SMCI
$26B
$4.54M 0.63%
1,300,750
+173,160
+15% +$541K
TUBE
18
DELISTED
TubeMogul, Inc.
TUBE
$4.37M 0.61%
+193,796
New +$3.13M
HA
19
DELISTED
Hawaiian Holdings, Inc.
HA
$4.33M 0.6%
166,419
+99,258
+148% +$1.87M
LDRH
20
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$4.32M 0.6%
131,692
+41,505
+46% +$1.36M
PGNX
21
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$4.18M 0.58%
+553,309
New +$3.31M
NVAX icon
22
Novavax
NVAX
$1.69B
$4.14M 0.58%
34,884
+12,241
+54% +$1.28M
AMAG
23
DELISTED
AMAG Pharmaceuticals
AMAG
$4.12M 0.57%
96,558
+8,692
+10% +$314K
VRNS icon
24
Varonis Systems
VRNS
$5.29B
$4.09M 0.57%
+373,545
New +$2.85M
OMER icon
25
Omeros
OMER
$1.37B
$4.08M 0.57%
164,544
+20,212
+14% +$368K
1
2 3 4 5

Similar funds

PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
HWCM
Hudson Way Capital Management Dallas, Texas $1.12B AUM 10.35% 1-Year Est. Return
WMN
Wealth Management Nebraska Norfolk, Nebraska $1.12B AUM 20.18% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $1.12B AUM 24.07% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $1.12B AUM 150.26% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $1.12B AUM

EAM Investors's Q4 2014 Portfolio in Review

As of Q4 2014, EAM Investors held 426 positions worth $717M, up 46% from $492M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

EAM Investors deployed $115M of net new capital in Q4 2014, opening 116 new positions and adding to 108 existing holdings. Its largest new stake was Callidus Software, Inc.: 247,614 shares worth $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was STRATTEC Security, an estimated $1.37M trimmed.

  • EAM Investors's largest Q4 2014 buy was Callidus Software, Inc.: 247,614 shares worth $4.04M.
  • EAM Investors added most to Esperion Therapeutics in Q4 2014, an estimated $3.52M increase.
  • EAM Investors's biggest Q4 2014 reduction was STRATTEC Security, cutting an estimated $1.37M.
  • EAM Investors fully exited Pixelworks in Q4 2014, selling an estimated $3.85M.
  • EAM Investors's ten largest holdings make up 8.6% of its $717M portfolio in Q4 2014.
  • EAM Investors opened 116 new positions and closed 120 in Q4 2014.
  • EAM Investors's portfolio value rose 46% quarter-over-quarter to $717M.

Based on EAM Investors's 13F filing for Q4 2014, filed 9 Feb 2015.